Market Overview

Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference


Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced
that it will present at the following investor conference in September:

Baird Global Healthcare Conference
New York, NY
Date: Wednesday, September 5, 2018
10:50 a.m. ET
Speakers: Dr. August Troendle, President & Chief
Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief
Operating Officer, Laboratory Operations

A live webcast of each presentation will be accessible through the
"Investors" section of the Company's website at
and will be available for replay following each event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical
contract research organization (CRO) providing Phase I-IV clinical
development services to the biotechnology, pharmaceutical and medical
device industries. Medpace's mission is to accelerate the global
development of safe and effective medical therapeutics through its
high-science and disciplined operating approach that leverages
regulatory and therapeutic expertise across all major areas including
oncology, cardiology, metabolic disease, endocrinology, central nervous
system and anti-viral and anti-infective. Headquartered in Cincinnati,
Ohio, Medpace employs approximately 2,700 people across 36 countries.

View Comments and Join the Discussion!